During the course of in vitro screening of agents which are preferentially active against ras oncogene-expressed cells, a new anthracycline (identified as 2-demethylsteffimycin D) and a heptaene (possibly a new member of partricins) were isolated from microbial fermentation broths. Among knowncompounds tested, 5-fluorouracil, 5-fluorodeoxyuridine and oxanosine showed high selectivity towards ras oncogene-expressedcells. 1489 An ideal antitumor drug should be one that is active against tumor cells but not active against normal cells. Therefore, it is desirable to determine effects of a potential antitumor compoundon appropriate pairs of tumor cells and normal cells early in a screening program. It is knownthat malfunctioning of cellular oncogenes is a cause of humancancer1j2), and manyhumancancers appear to be associated with the expression of activated ras genes3). We, therefore, have been screening in vitro microbial products which are preferentially active against ras oncogene-expressed cells. Two pairs of oncogene-expressed (ras+) and unexpressed (ras~) types of cells are used in our screening: (1) a rat kidney cell line integrating temperature sensitive v-K-ras (rastsNRK), grown at 33°C (ras+) and at 39°C (ras~), and (2) another rat kidney cell line integrating the wild type v-K-ras (rasNRK, ras+) and any of the two nontumorous rat kidney cell lines (either NRK-52Eor NRK-49F, ras'). The cell lines of (2) were grown at an ordinary temperature, 37°C. With these cell lines, two types of screening were conducted: One was to find antibiotics which would preferentially inhibit the growth of ras+ cells (Effect A). The other was to find antibiotics which would alter the tumor cell morphology ofras+ cells to the normal cell morphology of ras~cells (Effect B). In our screening study, we have isolated a new anthracycline with Effects A and B and possibly a new heptaene with Effect A from microbial products. Various knowncompoundswere also tested for their possible effects in respect of Effects Aand/or B. This paper reports results of these studies.
(rastsNRK)4) was a gift of Dr. T. Y. Shih, NIH, Bethesda, MD. The following cell lines were obtained from ATCC:NRKinfected with the wild type Kirsten murine sarcoma virus (rasNRK) (strain CRL-1 569) and nontumorous NRK's (NRK-49F and NRK-52E) (strains CRL-1570 and CRL-1571, respectively). NOV. 1990 Cells were grown in Dulbecco's modified Eagle medium (DMEM; Nissui Pharm. Co., Tokyo) supplemented with lOO jUg/ml kanamycin (Meiji Seika Kaisha, Ltd., Tokyo) and 2~5% heat-inactivated calf serum (Gibco Lab., Grand Island, NY) at 33°C or 39°C for raytsNRK or at 37°C for the other cell lines, in 5% CO2-containg humidified air. Cells were seeded at a density of l~2 x 104 cells/2ml/well in Costar 12-well tissue culture clusters (day 0). The cells received test samples on day 1 and were incubated further until day 3. During the culture period, the cells were photographed, if necessary, on a Nikon NO. ll THE JOURNAL OF ANTIBIOTICS 1491 phase-contrast microscope (Diaphot-TMD) using Fuji Neopan SS films. Cell growth was determined as follows; cells were counted in a Coulter counter (a) or cells were stained with crystal violet (0.1% (w/v) in 20% methanol, 0.5 ml/well) followed by a brief wash with tap water, dried, and the dye was extracted into 0.001n HCl-30% ethanol (2ml/well) and the absorbance was determined at 570nm (b).
Both determinations produced closely paralleled result. Relative extent of growth in a test run was calculated based on the following equation:
Cellnumberinatestrunonday 3 -Cellnumberonday 1
Cell number in the control run onday 3 -Cell number on day 1 x100(%) Spectroscopy Mass spectra were recorded on a Jeol JMS-HX110 and Hitachi M-80 H. NMRspectra were recorded on a Jeol JUM-GX400spectrometer.
Results and Discussion
Isolation and Physico-chemical Properties of 2-Demethylstemmycin D, a NewMemberof Anthracyclines The producer strain, Streptomyces sp. MH538-30F7, was cultured after an inoculation of 3% of a seed culture broth at 27°C for 7 days in jar fermenters (Marubishi MSJ-U 301) each containing 15 liters of the production medium(see below), under aeration of 15 liters/minute/jar and stirring at 200 rpm. The production medium consisted of corn steep liquor 1.0%, Polypeptone 0.5%, yeast extract 0.2%, NaCl 0.1%, glucose 1.0%, potato starch 1.0%, glycerol 1.0% and CaCO30.3%, with the pH adjusted to 7.4 before autoclaving. Isolation procedures were as shown in Fig. 1 Tables 1 and 2 , respectively. It should be noted, in Table 1 Coupling constant (/= Hz). Table 2 . 13C NMRchemical shifts (100MHz, acetone-d6).
a Assignments may be interchanged. structure at positions 8 and 2' and (3) the lack of 3.98ppm signal in the new compound, as opposed to STF-D, indicated the absence of aromatic methoxyl. As shown in Table 2 , 13C NMRchemical shifts of the new compoundagreed well with those of STF-Dexcept that the former lacked 56.8ppm peak of methoxyl and that there were some differences for C-2 and its neighbors, C-l and C-3. All these data indicated that the newly isolated compound was 2-demethylsteffimycin D (dmSTF-D, Fig. 2 ).
Biological Activities of dmSTF-D dmSTF-D inhibited in vitro the growth of rasNRK more strongly than inhibited that of NRK-49F. Values represent /xg/ml except. a ODat 382nm. b Cell morphology altered. IC50 (the concentration of a drug required for 50% growth inhibition) for rasNRK and NRK-49F were 0.73^g/ml and 5.8 /xg/ml, respectively. No such selectivity was observed with STF-D and doxorubicin and the latter was somewhatmore toxic to NRK-49Fthan to rasNRK (Table 3) . Another characteristic of dmSTF-Dactivity towards ras+ cells was its ability to alter cell morphology from "transformed" to "normal-like" at concentrations somewhat higher than IC50 (Fig. 3) . No other anthracyclines showed this activity. dmSTF-Ddid not alter significantly the cell morphology of an NRKcell line expressing \-src even at concentrations totally inhibiting cell growth. Antibacterial activity of dmSTF-Dwas similar in One unit was defined as an enough amount (pil or jig) of any preparation to cause 50%inhibition of growth of rastsNRK at 33°C in the assay system described under methods.
ju-Bondapack sphere 5/mi C18-100A, 3.9mmx 15cm (Waters Co.) eluted with 0.05m sodium citrate-35% CH3CNat 1 ml/minute. CPC apparatus model NMF(Sanki Engineering Co.). Fig. 5 . HPLCprofile of the crude preparation (see Fig. 4 ). Fig. 6 . HPLC profile of the purified preparation (see Fig. 4 ).
spectrum to those of other steffimycins5) but only 1/4 to 1/8 as active as, for example, STF-B. The low yield of pure dmSTF-Dfrom fermentation broths has made further studies difficult. Isolation and Physico-chemical Properties of a Heptaene, Possibly a NewMemberof Partricins The producer strain, Streptomyces sp. SA-1795, was cultured upon an inoculation of 1%of a seed culture broth at 27°C for 5 days on a rotary shaker (180rpm) in 500-ml baffled Erlenmeyer flasks each containing 1 10ml of a production medium consisting of glycerol 2.5%, beef extract 0.5%, Polypeptone 0.5%, yeast extract 1.0%, NaCl 0.2%, MgSO4-7H2O 0.05%, KH2PO4 0.05%, and CaCO3 0.03% with the pH adjusted to 7.4 before autoclaving. The isolation procedure is shown in Fig. 4 Biological Activities of the Newly Isolated Heptaene The purified preparation inhibited the growth of rastsNRK at 33°C more strongly than inhibited at 39°C; IC50 for the 33°C (ras+) and 39°C (ras~) cultures were 0.04^g/ml and 0.12/jg/ml, respectively.
This heptaene failed to show such selectivity towards ras-expressed cells whentested with the pair of rasNRK (ras+) and NRK-52E (ras'); IC50 for the former and the latter were 0.12/zg/ml and 0.13 f/g/ml, respectively. The antibacterial spectrum of the newly isolated heptaene was like those of knownpolyenes; NOV. 1990 MIC Og/ml) values by the agar dilution method were Candida albicans IMC F-4 3147 (6.25), Saccharomyces cerevisiae IMC F-7 (3.12), Cryptococcus neoformans IMC F-10 (0.78), etc. Specific Effects of SomeknownCompoundson ras-Expressed Cells As described above, an attempt to find possible inhibitors of ras functions in fermentation broths of microorganisms led to isolation of 2-demethylsteffimycin D and a possibly new memberof partricins as candidates. The molecular mechanismsunderlying their effects have not been studied yet. In this connection, we have found that oxanosine, a guanosine analog, alters the transformed morphology of rastsNRK to the normal morphology by depleting guanine nucleotides and destabilizing p218) in the cells. Known antibiotics of various structures were tested for possible effect on either cell morphologyor cell growth and the results are summarized in Table 3 . 5-Fluorouracil (5FU) and 5-fluorodeoxyuridine (5FUdR) evidently inhibited growth of rasNRK (ras+) more strongly than inhibited that of NRK-52E (ras~), although no such selectivity was observed with rastsNRK grown at 33°C (ras+) and 39°C (ras~). The reason for the inconsistency remains unelucidated. Oxanosine and mycophenolic acid, both are inhibitors of inosine monophosphate (IMP) dehydrogenase, showed significant selectivity in inhibiting growth of ras+. Expression of an oncogene(s) mayalter IMP dehydrogenase to make it more susceptible to inhibitors, as we have shown using v-src expressed cells9'10). The cell growth inhibition by the two compounds accompanied alteration of cell morphology from "transformed" to "normal", as described above. No other compoundstested were found to alter cell morphology. Amphotericin B and trichomycin showed some selectivity with respect to cell growth inhibition. Mitomycin C, doxorubicin and cisplatin lacked the selectivity, suggesting that they may not be suitable for use in chemotherapy of ras-expressed tumors. 5FU and oxanosine in combination are being tested with mice inoculated with an NIH/3T3 strain integrating activated ras.
